Arteris, Inc. (NASDAQ:AIP) Director Saiyed Atiq Raza Sells 2,776 Shares

Arteris, Inc. (NASDAQ:AIP) Director Saiyed Atiq Raza sold 2,776 shares of the company’s stock in a transaction on Monday, January 6th. The stock was sold at an average price of $12.34, for a total value of $34,255.84. Following the sale, the director now owns 684,320 shares of the company’s stock, valued at approximately $8,444,508.80. This represents a 0.40 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Saiyed Atiq Raza also recently made the following trade(s):

• On Thursday, December 26th, Saiyed Atiq Raza sold 41,439 shares of Arteris stock. The stock was sold at an average price of $10.37, for a total value of $429,722.43.
• On Wednesday, December 18th, Saiyed Atiq Raza sold 12,166 shares of Arteris stock. The shares were sold at an average price of $10.07, for a total value of $122,511.62.
• On Wednesday, December 11th, Saiyed Atiq Raza sold 2,400 shares of Arteris stock. The shares were sold at an average price of $10.01, for a total transaction of $24,024.00.

Arteris Price Performance

Shares of AIP stock opened at $11.10 on Friday. The firm has a market capitalization of $445.96 million, a price-to-earnings ratio of -11.56 and a beta of 1.17. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.16 and a current ratio of 1.16. The stock’s 50-day simple moving average is $9.33 and its 200-day simple moving average is $8.18. Arteris, Inc. has a fifty-two week low of $4.83 and a fifty-two week high of $12.64.

Analyst Upgrades and Downgrades

Separately, Rosenblatt Securities reissued a “buy” rating and set a $15.00 target price on shares of Arteris in a research report on Wednesday, November 6th.

Institutional Investors Weigh In On Arteris

Several institutional investors and hedge funds have recently made changes to their positions in AIP. Bank of New York Mellon Corp purchased a new position in Arteris in the 2nd quarter worth $580,000. Rhumbline Advisers lifted its holdings in shares of Arteris by 2,182.8% during the second quarter. Rhumbline Advisers now owns 31,822 shares of the company’s stock worth $239,000 after purchasing an additional 30,428 shares during the period. Renaissance Technologies LLC boosted its position in Arteris by 6.1% in the second quarter. Renaissance Technologies LLC now owns 114,700 shares of the company’s stock valued at $861,000 after buying an additional 6,600 shares during the last quarter. CloudAlpha Capital Management Limited Hong Kong purchased a new position in Arteris during the 2nd quarter worth approximately $554,000. Finally, The Manufacturers Life Insurance Company acquired a new stake in Arteris during the 2nd quarter valued at approximately $86,000. 64.36% of the stock is currently owned by institutional investors and hedge funds.

Arteris Company Profile

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.